The effect of cocaine, reserpine, and 6-hydroxydopamine on the response of the perfused central artery of the rabbit ear to sympathomimetic amines.
The perfused central artery of the rabbit ear was less sensitive to extraluminal than to intraluminal noradrenaline, but the reverse was true for metaraminol, methoxamine, metanephrine, and isoproterenol. No difference was noted between the extraluminal and intraluminal potency of phenylephrine. Cocaine potentiated the effect of extraluminal and intraluminal noradrenaline, but decreased that of intraluminal phenylephrine. Irrespective of the route of administration, the constrictor potencies of the sympathomimetic amines were not affected by cocaine. Arteries of reserpine-treated rabbits were supersensitive to extraluminally and intraluminally applied noradrenaline and phenylephrine, but they were not supersensitive to metaraminol. 6-Hydroxydopamine effectively destroyed adrenergic nerve endings of the central ear artery and increased its responses to both extraluminal and intraluminal noradrenaline and phenylephrine. However, only the constrictor potencies of intraluminally applied metaraminol and methoxamine were enhanced by 6-hydroxydopamine. The apparent discrepancies between the results obtained by various procedures that eliminate or impair the nerve uptake process suggest that the difference in the constrictor potency of extraluminal and intraluminal sympathomimetic amines is probably unrelated to their uptake by nerves located in the adventitio-medial junction of the artery.
D000818:Animals; D001158:Arteries / Q000187:drug effects*; D003042:Cocaine / Q000494:pharmacology*; D004357:Drug Synergism; D004423:Ear / Q000098:blood supply*; D005260:Female; D006892:Hydroxydopamines / Q000494:pharmacology*; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008676:Metanephrine / Q000494:pharmacology; D008680:Metaraminol / Q000494:pharmacology; D008729:Methoxamine / Q000494:pharmacology; D009411:Nerve Endings / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology*; D013566:Sympathomimetics / Q000494:pharmacology*; D014666:Vasomotor System / Q000187:drug effects
D006892:Hydroxydopamines; D013566:Sympathomimetics; D010656:Phenylephrine; D008676:Metanephrine; D008680:Metaraminol; D012110:Reserpine; D008729:Methoxamine; D003042:Cocaine; D007545:Isoproterenol; D009638:Norepinephrine